vs
Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and Serve Robotics Inc. (SERV). Click either name above to swap in a different company.
Insight Molecular Diagnostics Inc. is the larger business by last-quarter revenue ($1.1M vs $881.5K, roughly 1.3× Serve Robotics Inc.). Insight Molecular Diagnostics Inc. runs the higher net margin — -2015.4% vs -3888.1%, a 1872.7% gap on every dollar of revenue. On growth, Serve Robotics Inc. posted the faster year-over-year revenue change (400.1% vs -23.4%). Insight Molecular Diagnostics Inc. produced more free cash flow last quarter ($-7.0M vs $-46.1M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -3.5%).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Ecovacs Robotics is a Chinese technology company. It is best known for developing in-home robotic appliances. The company was founded in 1998 by Qian Dongqi and is headquartered in Suzhou, China. According to Global Asia, Ecovacs Robotics had more than 60% of the Chinese market for robots by 2013. In 2023, Nikkei Asia had reported that the market capitalisation of Ecovacs Robotics has grown to near $6.38 billion, which is "roughly 5 times" that of the market capitalisation of rivalling US bas...
IMDX vs SERV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.1M | $881.5K |
| Net Profit | $-23.0M | $-34.3M |
| Gross Margin | 42.5% | -757.3% |
| Operating Margin | -2057.5% | -4572.1% |
| Net Margin | -2015.4% | -3888.1% |
| Revenue YoY | -23.4% | 400.1% |
| Net Profit YoY | 31.5% | -161.3% |
| EPS (diluted) | $-0.75 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1M | $881.5K | ||
| Q3 25 | $260.0K | $687.0K | ||
| Q2 25 | $518.0K | $642.0K | ||
| Q1 25 | $2.1M | $440.5K | ||
| Q4 24 | $1.5M | $176.3K | ||
| Q3 24 | $115.0K | $222.0K | ||
| Q2 24 | $104.0K | $468.0K | ||
| Q1 24 | $176.0K | $946.7K |
| Q4 25 | $-23.0M | $-34.3M | ||
| Q3 25 | $-10.9M | $-33.0M | ||
| Q2 25 | $-9.7M | $-20.9M | ||
| Q1 25 | $-6.7M | $-13.2M | ||
| Q4 24 | $-33.5M | $-13.1M | ||
| Q3 24 | $-13.5M | $-8.0M | ||
| Q2 24 | $-4.5M | $-9.0M | ||
| Q1 24 | $-9.1M | $-9.0M |
| Q4 25 | 42.5% | -757.3% | ||
| Q3 25 | 53.5% | -637.4% | ||
| Q2 25 | 67.6% | -445.3% | ||
| Q1 25 | 62.0% | -333.4% | ||
| Q4 24 | 40.0% | -371.7% | ||
| Q3 24 | 43.5% | -70.3% | ||
| Q2 24 | 48.1% | 30.3% | ||
| Q1 24 | 25.6% | 62.8% |
| Q4 25 | -2057.5% | -4572.1% | ||
| Q3 25 | -4249.2% | -5067.8% | ||
| Q2 25 | -1900.0% | -3527.1% | ||
| Q1 25 | -318.0% | -3406.6% | ||
| Q4 24 | -2262.9% | -7701.3% | ||
| Q3 24 | -11752.2% | -3804.1% | ||
| Q2 24 | -4453.8% | -1828.2% | ||
| Q1 24 | -5265.3% | -814.6% |
| Q4 25 | -2015.4% | -3888.1% | ||
| Q3 25 | -4174.6% | -4806.4% | ||
| Q2 25 | -1880.7% | -3247.7% | ||
| Q1 25 | -312.0% | -3000.5% | ||
| Q4 24 | -2255.1% | -7441.8% | ||
| Q3 24 | -11733.0% | -3601.8% | ||
| Q2 24 | -4355.8% | -1931.2% | ||
| Q1 24 | -5186.9% | -954.7% |
| Q4 25 | $-0.75 | $-0.50 | ||
| Q3 25 | $-0.34 | $-0.54 | ||
| Q2 25 | $-0.30 | $-0.36 | ||
| Q1 25 | $-0.26 | $-0.23 | ||
| Q4 24 | $-2.19 | $-0.23 | ||
| Q3 24 | $-0.98 | $-0.20 | ||
| Q2 24 | $-0.36 | $-0.27 | ||
| Q1 24 | $-1.13 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $106.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-31.5M | $350.7M |
| Total Assets | $25.8M | $367.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $106.2M | ||
| Q3 25 | $18.7M | $116.8M | ||
| Q2 25 | $24.3M | $116.7M | ||
| Q1 25 | $31.0M | $197.8M | ||
| Q4 24 | $8.6M | $123.3M | ||
| Q3 24 | $3.4M | $50.9M | ||
| Q2 24 | $9.3M | $28.8M | ||
| Q1 24 | $5.6M | — |
| Q4 25 | $-31.5M | $350.7M | ||
| Q3 25 | $-9.2M | $283.9M | ||
| Q2 25 | $1.1M | $207.2M | ||
| Q1 25 | $10.2M | $210.2M | ||
| Q4 24 | $-12.3M | $131.7M | ||
| Q3 24 | $9.7M | $56.2M | ||
| Q2 24 | $22.7M | $28.5M | ||
| Q1 24 | $11.6M | $-8.8M |
| Q4 25 | $25.8M | $367.8M | ||
| Q3 25 | $43.9M | $299.1M | ||
| Q2 25 | $50.5M | $214.3M | ||
| Q1 25 | $60.4M | $216.6M | ||
| Q4 24 | $35.1M | $139.6M | ||
| Q3 24 | $70.2M | $61.5M | ||
| Q2 24 | $74.7M | $32.8M | ||
| Q1 24 | $71.0M | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-29.6M |
| Free Cash FlowOCF − Capex | $-7.0M | $-46.1M |
| FCF MarginFCF / Revenue | -616.7% | -5234.4% |
| Capex IntensityCapex / Revenue | 129.9% | 1872.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.4M | $-117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.5M | $-29.6M | ||
| Q3 25 | $-4.5M | $-25.2M | ||
| Q2 25 | $-6.3M | $-16.0M | ||
| Q1 25 | $-5.9M | $-9.5M | ||
| Q4 24 | $-5.4M | $-6.3M | ||
| Q3 24 | $-5.5M | $-5.5M | ||
| Q2 24 | $-6.0M | $-5.7M | ||
| Q1 24 | $-3.8M | $-4.1M |
| Q4 25 | $-7.0M | $-46.1M | ||
| Q3 25 | $-5.6M | $-36.5M | ||
| Q2 25 | $-6.6M | $-22.0M | ||
| Q1 25 | $-6.2M | $-12.9M | ||
| Q4 24 | $-5.6M | $-11.1M | ||
| Q3 24 | $-5.6M | $-10.1M | ||
| Q2 24 | $-6.2M | $-6.5M | ||
| Q1 24 | $-3.9M | $-4.1M |
| Q4 25 | -616.7% | -5234.4% | ||
| Q3 25 | -2135.4% | -5314.1% | ||
| Q2 25 | -1279.5% | -3426.8% | ||
| Q1 25 | -288.4% | -2934.1% | ||
| Q4 24 | -374.5% | -6307.8% | ||
| Q3 24 | -4884.3% | -4529.7% | ||
| Q2 24 | -5931.7% | -1396.6% | ||
| Q1 24 | -2189.8% | -431.1% |
| Q4 25 | 129.9% | 1872.1% | ||
| Q3 25 | 403.8% | 1649.6% | ||
| Q2 25 | 67.4% | 940.4% | ||
| Q1 25 | 14.4% | 785.7% | ||
| Q4 24 | 14.4% | 2755.1% | ||
| Q3 24 | 75.7% | 2070.7% | ||
| Q2 24 | 183.7% | 169.8% | ||
| Q1 24 | 13.6% | 0.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.